Chronic Kidney Disease: Risk Factors, Symptoms, and Prevention Guide (2026)

Chronic kidney disease (CKD) is one of medicine's most dramatic examples of a "silent" condition. It affects an estimated 850 million people globally and around 37 million Americans — roughly 15% of the adult population. The staggering part: 9 in 10 people with CKD don't know they have it. By the time symptoms appear, significant damage has often already occurred. This makes early detection and prevention genuinely life-saving knowledge.

How Your Kidneys Work — and Why It Matters

Your kidneys are remarkable organs — each about the size of a fist, filtering approximately 200 liters of blood every single day. They remove waste products and excess fluid, regulate blood pressure through the renin-angiotensin-aldosterone system, balance electrolytes (sodium, potassium, phosphorus), produce erythropoietin (stimulating red blood cell production), and activate vitamin D for bone health.

Each kidney contains about one million tiny filtering units called nephrons. The key problem with kidney disease: nephrons can't regenerate. Once destroyed, they're gone permanently. This is why protecting kidney function before damage occurs is so much more effective than treating damage after the fact.

The Stages of Chronic Kidney Disease

CKD is classified by GFR — Glomerular Filtration Rate — which measures how well the kidneys filter waste from blood. A normal GFR is above 90 mL/min/1.73m²:

Along with GFR, the amount of protein in the urine (albuminuria) is used to assess CKD severity and prognosis — higher albuminuria indicates more damage and faster progression.

What Causes Chronic Kidney Disease?

The Two Leading Causes

Diabetes (diabetic nephropathy): The single most common cause of CKD globally — responsible for approximately 44% of kidney failure cases in the United States. High blood glucose damages the delicate blood vessels in kidney glomeruli over years to decades. Early diabetic kidney disease is detectable as microalbuminuria (small amounts of albumin in urine) long before GFR declines — making screening in diabetics crucial.

Hypertension (hypertensive nephropathy): The second most common cause — responsible for 28% of kidney failure cases. High blood pressure damages kidney vasculature directly. The relationship is bidirectional: CKD worsens hypertension, which further damages the kidneys — a destructive feedback loop.

Other Important Causes

• Glomerulonephritis — inflammation of the glomeruli from autoimmune conditions (IgA nephropathy is the most common worldwide), post-infectious causes, or vasculitis
• Polycystic kidney disease (PKD) — genetic condition causing multiple cysts to develop in kidneys; the most common inherited kidney disease
• Lupus nephritis — kidney involvement in systemic lupus erythematosus
• Recurrent kidney infections (pyelonephritis)
• Obstructive uropathy — blockage from kidney stones, enlarged prostate, or structural abnormalities
• Medications — NSAIDs (a major and underappreciated cause), contrast dyes, certain antibiotics (aminoglycosides), and others
• Obesity — an independent risk factor for CKD beyond its effects through diabetes and hypertension

Symptoms — Why CKD Is So Often Missed

The kidneys have enormous functional reserve — you can lose more than 70% of kidney function before symptoms clearly appear. This is why people with GFR in the 30s and even 20s often feel "fine." When symptoms do develop, they're typically non-specific and easily attributed to other causes:

• Fatigue — from anemia (reduced erythropoietin) and accumulating metabolic waste
• Swelling (edema) — in ankles, feet, legs, and around the eyes, from fluid retention and protein loss
• Decreased urine output — or conversely, increased nighttime urination (nocturia) as the kidneys lose concentrating ability
• Foamy urine — protein in urine creates bubbles that don't dissipate
• High blood pressure — both cause and consequence of CKD
• Shortness of breath — from fluid overload or anemia
• Nausea and loss of appetite — from uremia (accumulation of nitrogenous waste)
• Muscle cramps — from electrolyte abnormalities, particularly low calcium and high phosphorus
• Itching — from phosphate accumulation and uremic toxins depositing in skin
• Cognitive changes — "uremic brain fog"

Diagnosis: Key Tests

eGFR (estimated GFR) — calculated from serum creatinine, age, and sex. The primary measure of kidney function. Note: creatinine doesn't rise above normal until GFR has dropped below 50% — which is why "normal creatinine" doesn't mean "normal kidney function."

Urine albumin-to-creatinine ratio (UACR) — measures protein in the urine. Normal is below 30 mg/g. Microalbuminuria (30–300 mg/g) indicates early kidney damage; macroalbuminuria (above 300) indicates established nephropathy.

Who should be screened? The American Kidney Fund recommends annual screening (eGFR + UACR) for anyone with: diabetes, hypertension, family history of kidney disease, cardiovascular disease, age over 60, or history of recurrent kidney stones or urinary tract infections.

Evidence-Based Prevention Strategies

Control Blood Pressure Aggressively

Target blood pressure in CKD: below 130/80 mmHg — and even lower (below 120/80) may benefit patients with significant proteinuria based on the SPRINT trial findings. Every 10 mmHg reduction in systolic blood pressure significantly slows CKD progression and reduces cardiovascular risk (which is greatly elevated in CKD).

First-line antihypertensives for CKD: ACE inhibitors (lisinopril, ramipril) or ARBs (losartan, valsartan) — these not only lower blood pressure but also have direct kidney-protective effects by reducing intraglomerular pressure and proteinuria, independent of their BP effects. They're particularly crucial in diabetic nephropathy.

Optimize Blood Sugar Control

For people with diabetes, maintaining HbA1c below 7% significantly slows diabetic nephropathy progression. SGLT-2 inhibitors (empagliflozin, dapagliflozin, canagliflozin) have emerged as game-changers — they reduce kidney disease progression by 30–40% independent of their glucose-lowering effects. The DAPA-CKD trial showed dapagliflozin reduced the risk of kidney failure or cardiovascular death by 39% in CKD patients. SGLT-2 inhibitors are now recommended as a cornerstone of CKD management in people with or without diabetes.

Avoid Nephrotoxic Medications

NSAIDs (ibuprofen, naproxen, diclofenac) are one of the most underappreciated causes of kidney damage — both acute and chronic. They reduce renal blood flow and can precipitate acute kidney injury, particularly in people who are dehydrated, elderly, or have pre-existing CKD. People with any degree of kidney disease or significant cardiovascular disease should use acetaminophen (paracetamol) for pain instead, discuss the situation with their doctor, and avoid regular NSAID use.

Contrast dye (iodinated contrast used in CT scans) can cause contrast-induced nephropathy. Inform your radiologist of any kidney disease — alternative imaging, contrast minimization, or IV hydration protocols can reduce risk.

The Kidney Diet: Key Principles

In earlier CKD stages (G1–G3), dietary modifications are less restrictive. As CKD advances, more specific restrictions become important:

Sodium: Limit to below 2,000–2,300mg daily to control blood pressure, reduce edema, and slow CKD progression. Avoid processed foods, which account for 70%+ of dietary sodium.

Protein: The evidence on protein restriction in CKD is nuanced. Moderate protein restriction (0.6–0.8g/kg body weight) may slow CKD progression in non-diabetic patients — high protein intake increases glomerular filtration pressure. However, protein restriction must be carefully managed to avoid malnutrition. Work with a renal dietitian for individualized guidance.

Potassium: In advanced CKD, the kidneys can't excrete potassium efficiently, risking dangerous hyperkalemia (which can cause cardiac arrhythmias). High-potassium foods (bananas, oranges, potatoes, tomatoes, nuts) may need to be limited in advanced CKD.

Phosphorus: Advanced kidneys can't excrete phosphorus effectively — elevated phosphate damages blood vessels and bones. Limit dairy, processed foods with phosphate additives (fast food, cola beverages), and certain whole grains in G4–G5.

Fluids: In early CKD, adequate hydration is beneficial. In advanced CKD or dialysis, fluid restriction may be needed based on urine output. Let symptoms and your nephrologist guide you.

Manage Cardiovascular Risk Factors

People with CKD are far more likely to die from cardiovascular disease than progress to kidney failure — CKD is a major cardiovascular risk factor, increasing heart disease risk 5–10 fold. Statins, smoking cessation, weight management, and physical activity are all important for cardiovascular risk reduction in CKD.

Avoid Smoking

Smoking is an independent risk factor for CKD progression — it reduces renal blood flow, increases proteinuria, and accelerates kidney function decline. Quitting smoking reduces the rate of GFR decline and cardiovascular risk simultaneously.

SGLT-2 Inhibitors: A 2024–2026 Update

The kidney-protective effects of SGLT-2 inhibitors have now been demonstrated across multiple major clinical trials (CREDENCE, DAPA-CKD, EMPA-KIDNEY) and have genuinely changed how nephrologists practice. These medications are now recommended for:

• All patients with Type 2 diabetes and CKD (GFR 20–60), regardless of glucose control
• CKD with significant proteinuria (UACR above 200) even without diabetes
• Heart failure with CKD

If you have CKD and are not on an SGLT-2 inhibitor, it's worth discussing this with your nephrologist or primary care physician — the evidence for kidney protection is now very strong.

Frequently Asked Questions